Concepedia

Author

Michelle L. VanLith

University of Nebraska Medical Center

Also Known As

M L VanLith, M VanLith, M. L. VanLith, Michelle L VanLith, Michelle L. VanLith, Michelle VanLith

9

Publications

437

Citations

6

H-Index

23

Concepts

All Affiliations

University of Nebraska Medical CenterMayo Clinic in ArizonaNebraska Medical Center
ML

About

Michelle L. VanLith is an author at University of Nebraska Medical Center specializing in cell biology, medicine, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

416

2

Cell Biology

5

5

416

3

Immunology

4

4

322

4

Engineering

1

1

94

5

Molecular Biology

1

1

94

Michelle L. VanLith

×

6

Publications

435

Citations

6

H-Index

YearCitations

Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model.

Gerald J. Rowse, Richard M. Tempero, Michelle L. VanLith,

PubMed

1998

208

The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis

Nicolas Moniaux, Christophe Némos, Bruno M. Schmied,

Oncogene

2006

94

CD4+ Lymphocytes Provide MUC1-Specific Tumor Immunity In Vivo That Is Undetectable In Vitro and Is Absent in MUC1 Transgenic Mice

Richard M. Tempero, Michelle L. VanLith, Keita Morikane,

The Journal of Immunology

1998

66

Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1)

Karl G. Kohlgraf, Andrew J. Gawron, Michiyo Higashi,

Cancer Immunology Immunotherapy

2004

33

MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses

Michelle L. VanLith

International Immunology

2002

19

Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines

Connie L. Sivinski, Karl G. Kohlgraf, Michelle L. VanLith,

Cancer Immunology Immunotherapy

2002

15

Page 1